Trials (Feb 2020)

A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: protocol and rationale of the Take a STAND for Health study

  • Ana Jessica Pinto,
  • Tiago Peçanha,
  • Kamila Meireles,
  • Fabiana Braga Benatti,
  • Karina Bonfiglioli,
  • Ana Lúcia de Sá Pinto,
  • Fernanda Rodrigues Lima,
  • Rosa Maria Rodrigues Pereira,
  • Maria Claudia Costa Irigoyen,
  • James Edward Turner,
  • John P. Kirwan,
  • Neville Owen,
  • David W. Dunstan,
  • Hamilton Roschel,
  • Bruno Gualano

DOI
https://doi.org/10.1186/s13063-020-4104-y
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Patients with rheumatoid arthritis spend most of their daily hours in sedentary behavior (sitting), a predisposing factor to poor health-related outcomes and all-cause mortality. Interventions focused on reducing sedentary time could be of novel therapeutic relevance. However, studies addressing this topic remain scarce. We aim to investigate the feasibility and efficacy of a newly developed intervention focused on reducing sedentary time, and potential clinical, physiological, metabolic and molecular effects in rheumatoid arthritis. Methods The Take a STAND for Health study is a 4-month, parallel-group, randomized controlled trial, in which postmenopausal patients with rheumatoid arthritis will set individually tailored, progressive goals to replace their sedentary time with standing and light-intensity activities. Patients will be recruited from the Clinical Hospital (School of Medicine, University of Sao Paulo) and will be assessed at baseline and after a 4-month follow up. Outcomes will include objectively measured sedentary behavior (primary outcome) and physical activity levels, clinical parameters, anthropometric parameters and body composition; aerobic fitness, muscle function, blood pressure, cardiovascular autonomic function, vascular function and structure, health-related quality of life, and food intake. Blood and muscle samples will be collected for assessing potential mechanisms, through targeted and non-targeted approaches. Discussion Findings will be of scientific and clinical relevance with the potential to inform new prescriptions focused on reducing sedentary behavior, a modifiable risk factor that thus far has been overlooked in patients with rheumatoid arthritis. Trial registration ClinicalTrials.gov, NCT03186924. Registered on 14 June 2017.

Keywords